Extension of Time to File SOU

BATON

Eli Lilly and Company

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88057276
LAW OFFICE ASSIGNED LAW OFFICE 107
MARK SECTION
MARK BATON (see, http://uspto.report/TM/88057276/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT BATON
OWNER SECTION (current)
NAME Eli Lilly and Company
MAILING ADDRESS Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46285
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 317-651-1346
FAX 317-276-1919
EMAIL XXXX
OWNER SECTION (proposed)
NAME Eli Lilly and Company
MAILING ADDRESS Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46285
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 317-651-1346
FAX 317-276-1919
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Bruce W. Longbottom
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@lilly.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) longbottom_bruce@lilly.com
CORRESPONDENCE INFORMATION (proposed)
NAME Bruce W. Longbottom
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@lilly.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) longbottom_bruce@lilly.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Insulin pen modules, namely, insulin injectors sold filled with insulin, utilizing wireless technology
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 009
CURRENT IDENTIFICATION Computer software application for management of diabetes related data; Downloadable cloud computing software for use in managing diabetes
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 010
CURRENT IDENTIFICATION Dose detection modules attachable to insulin pens for transmission of data utilizing wireless technology
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Medical information services in the field of diabetes
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 4
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 02/12/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 4
SUBTOTAL AMOUNT [EXTENSION FEE] 500
TOTAL AMOUNT 500
SIGNATURE SECTION
SIGNATURE /blongbottom/
SIGNATORY'S NAME Bruce W. Longbottom
SIGNATORY'S POSITION Assistant General Counsel
DATE SIGNED 01/22/2021
SIGNATORY'S PHONE NUMBER 317 651 1346
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Fri Jan 22 12:20:18 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XX-2
0210122122018947762-88057
276-760951c56283dee1010b6
13b952c6828c11134b37b3762
5b9639dc8fc94697fa-DA-201
70145-2021012117483307315
6



PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: BATON (see, http://uspto.report/TM/88057276/mark.png)
SERIAL NUMBER: 88057276

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Eli Lilly and Company, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      Phone: 317-651-1346
      Fax: 317-276-1919
      Email: XXXX
Proposed: Eli Lilly and Company, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      Phone: 317-651-1346
      Fax: 317-276-1919
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 02/12/2019.

For International Class 005:
Current identification: Insulin pen modules, namely, insulin injectors sold filled with insulin, utilizing wireless technology

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 009:
Current identification: Computer software application for management of diabetes related data; Downloadable cloud computing software for use in managing diabetes

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 010:
Current identification: Dose detection modules attachable to insulin pens for transmission of data utilizing wireless technology

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 044:
Current identification: Medical information services in the field of diabetes

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the fourth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Bruce W. Longbottom
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@lilly.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): longbottom_bruce@lilly.com

Correspondence Information (proposed):
      Bruce W. Longbottom
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@lilly.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): longbottom_bruce@lilly.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $500 will be submitted with the form, representing payment for 4 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /blongbottom/      Date Signed: 01/22/2021
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Assistant General Counsel
Signatory's Phone: 317 651 1346
Signature method: Sent to third party for signature

PAYMENT: 88057276
PAYMENT DATE: 01/22/2021

Serial Number: 88057276
Internet Transmission Date: Fri Jan 22 12:20:18 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XX-2021012212201894
7762-88057276-760951c56283dee1010b613b95
2c6828c11134b37b37625b9639dc8fc94697fa-D
A-20170145-20210121174833073156




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed